Signal transducer and activator of transcription 1-alpha (STAT1α)

Signal transducer and activator of transcription 1-alpha (STAT1α) is a pivotal transcription factor that mediates cellular responses to interferons (IFNs) and various cytokines, playing a central role in the innate and adaptive immune systems (UniProt P42224). Upon cytokine binding to cell surface receptors, STAT1α is phosphorylated by Janus kinases (JAKs), leading to its dimerization and translocation into the nucleus where it binds to specific DNA elements to initiate the transcription of interferon-stimulated genes (ISGs) (PubMed: 30073104). It is particularly vital for the signaling of Type I and Type II interferons, which are essential for antiviral and antibacterial defense. In oncology, STAT1α often functions as a tumor suppressor by promoting apoptosis and inhibiting the cell cycle, yet its chronic activation can contribute to an "interferon-related resistance signature" that protects tumor cells from radiotherapy and chemotherapy (PubMed: 27510034). Mutations in the STAT1 gene can lead to primary immunodeficiencies or gain-of-function autoimmune diseases, making it a significant target for therapeutic modulation (StatPearls: NBK560680). While direct inhibitors like fludarabine and experimental small molecules are being explored, the protein's dual role in immunity and malignancy necessitates precise therapeutic intervention to avoid severe immunosuppression or paradoxical disease progression.

Other names

STAT1Signal transducer and activator of transcription 1, 91kDaISGF-3CANDF7IMD31AIMD31BIMD31C

Inhibition of STAT1 protein expression, prevention of tyrosine phosphorylation by Janus kinases, or blockade of SH2 domain-mediated dimerization and subsequent nuclear translocation (PMID: 11418531, PubMed: 30073104).